But as the malignant tumor tissue is generally in hypoxic state,5 and the MGMT inhibition effect of FM19G11 majorly relies on the hypoxia‐inducible factor‐1‐alpha pathway, we think FM19G11 probably preferentially inhibit MGMT activity in tumor than in the normal tissues. The gene discussed is HIF1A; the disease is neoplasm.